Cite
Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays.
MLA
Lau, C. S., et al. “Performance of the Roche/Snibe Electrochemiluminescent Anti-SARS-COV-2 Spike Assays Compared to the Roche/Abbott IgG Nucleocapsid and Abbott IgM Spike Assays.” Practical Laboratory Medicine, vol. 27, Nov. 2021, p. e00257. EBSCOhost, https://doi.org/10.1016/j.plabm.2021.e00257.
APA
Lau, C. S., Wong, M. S., Hoo, S. P., Heng, P. Y., Phua, S. K., & Aw, T. C. (2021). Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays. Practical Laboratory Medicine, 27, e00257. https://doi.org/10.1016/j.plabm.2021.e00257
Chicago
Lau, C S, M S Wong, S P Hoo, P Y Heng, S K Phua, and T C Aw. 2021. “Performance of the Roche/Snibe Electrochemiluminescent Anti-SARS-COV-2 Spike Assays Compared to the Roche/Abbott IgG Nucleocapsid and Abbott IgM Spike Assays.” Practical Laboratory Medicine 27 (November): e00257. doi:10.1016/j.plabm.2021.e00257.